POPULATION STUDIES AND DISPARITIES RESEARCH – ABSTRACT
The Population Studies and Disparities Research (PSDR) Program is committed to identifying key genetic
and behavioral risk factors underlying disease onset and progression and developing and testing novel
intervention strategies to reduce risk and improve diagnosis, treatment, and outcomes with an emphasis on
reducing and/or eliminating cancer health disparities among populations contained within our catchment area.
This interactive Program includes 28 members from 11 departments and 3 schools at Wayne State University
and $6,936,093 in peer reviewed, cancer-related funding, of which $5,793,590 is from the NCI. The PSDR
Program has two overarching scientific themes. The first theme is to investigate the distribution and
determinants of cancer risk, survivorship, and outcomes in a racially and ethnically diverse population. Major
scientific investigations under this theme use emerging advances in genetics to address our highly-diverse
catchment area population that is approximately 25% African American, includes the largest Arab-American
community in the US; developing projects target both sexual and gender minority cancer survivors and rural
populations within our expanded catchment area. The work is supported by the Detroit area population-based
cancer registry, a founding participant in the SEER Program, a resource that is well-leveraged for extensive
population-based studies of the epidemiology of lung, breast, prostate, colon, ovarian, and endometrial cancers
in diverse populations. The second theme is to develop and test evidence-based interventions focused on
patient, family member, and physician behaviors to reduce disparities in cancer prevention, treatment,
survivorship, and end-of-life outcomes. The main focus of this theme is modifying social and behavioral factors
driving risk behaviors, screening and treatment choices, the quality of physician-patient-family member
communication, symptom management, and survivorship in racially and ethnically diverse adult and pediatric
populations. The work is supported by a unique, custom-designed video data capture system installed in multiple
clinic sites to study the ways racial bias and poor communication give rise to unequal treatment decisions and
health outcomes. Future directions include the development of multi-PI grants focused on African American
cancer survivors, leveraging the Detroit Research on Cancer Survivors (Detroit ROCS) cohort study. The Detroit
ROCS study is the largest single cohort conducted exclusively among African American cancer survivors with a
goal of understanding the determinants of poorer outcomes in this population. eHealth technologies to enhance
patient-provider communication are also being developed. PSDR Program members actively collaborate with
members of the MI, MT, and TBM Programs at KCI. Of the 409 manuscripts published from December 2015
to November 2019, 43% and 25% were intra- and inter-programmatic, respectively, and 74% were multi-
institutional collaborations.
Public Health Relevance Statement
Data not available.
NIH Spending Category
No NIH Spending Category available.
Project Terms
AccelerationAddressAdmixtureAdultAffectAfrican AmericanAmericanArabsAreaAutomobile DrivingBehavioralCancer Center Support GrantCancer SurvivorCancer SurvivorshipCatchment AreaCharacteristicsChildhoodClinicClinicalCohort StudiesCollaborationsColon CarcinomaCommunicationCommunication ResearchCommunitiesComprehensive Cancer CenterCustomDataDevelopmentDiagnosisDiscriminationDisease ProgressionDisparityEndometrial CarcinomaEpigenetic ProcessEthnic OriginEvidence based interventionFamily memberFundingFutureGeneticGoalsGrantHealthImmunityIncidenceIndividualInflammationInstitutionInterventionInvestigationLesbian Gay Bisexual TransgenderMalignant Breast NeoplasmMalignant NeoplasmsMalignant neoplasm of lungMalignant neoplasm of ovaryMalignant neoplasm of prostateManuscriptsMetabolic syndromeMichiganMinorityMinority GroupsMissionMolecularMolecular Epidemiology of CancerObesityOnset of illnessOutcomeParticipantPatient-Focused OutcomesPatientsPeer ReviewPhysical activityPhysiciansPopulationPopulation HeterogeneityPopulation StudyPrognosisPublishingQuality of CareRaceReduce health disparitiesResearchResearch Project GrantsResourcesRiskRisk BehaviorsRisk FactorsRisk ReductionRoleRural MinorityRural PopulationSEER ProgramSchoolsSexual and Gender MinoritiesSiteSmokingSurvivorsSusceptibility GeneSystemTargeted ResearchTechnologyTestingUnderserved PopulationUnited StatesUniversitiesWorkanalytical methodbiomarker discoverycancer diagnosiscancer epidemiologycancer health disparitycancer preventioncancer riskclinical practiceclinical research sitecohortcommunity based researchcomorbiditydefined contributiondesigndisparity eliminationdisparity reductioneHealthend of life outcomesepidemiology studyethnic diversityexperiencefamily geneticsgender minority grouphealth equityheritability patternhigh riskhigh risk populationimprovedinterestmedically underservedmembermetropolitanmortalityneoplasm registrynoveloutreachpatient-clinician communicationpopulation basedpopulation healthpreclinical studyprogramsprovider behaviorpsychosocialracial biasracial disparityracial diversityrecruitrisk stratificationscreeningsexual minority groupsocialsurvivorshipsymptom managementtheoriestreatment choicetumor
No Sub Projects information available for 5P30CA022453-42 8819
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 5P30CA022453-42 8819
Patents
No Patents information available for 5P30CA022453-42 8819
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 5P30CA022453-42 8819
Clinical Studies
No Clinical Studies information available for 5P30CA022453-42 8819
News and More
Related News Releases
No news release information available for 5P30CA022453-42 8819
History
No Historical information available for 5P30CA022453-42 8819
Similar Projects
No Similar Projects information available for 5P30CA022453-42 8819